Cargando…
Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment
Treatment of eosinophilic gastroenteritis (EGE) is mainly empirical and is based on the assessment of symptom severity and the experience of clinicians. Patients with mild disease can be treated symptomatically, while patients with more severe symptoms or malabsorption symptoms require more aggressi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395056/ https://www.ncbi.nlm.nih.gov/pubmed/37538288 http://dx.doi.org/10.5114/pg.2022.118635 |
_version_ | 1785083507800801280 |
---|---|
author | Kuźmiński, Andrzej Rosada, Tomasz Przybyszewska, Justyna Ukleja-Sokołowska, Natalia Bartuzi, Zbigniew |
author_facet | Kuźmiński, Andrzej Rosada, Tomasz Przybyszewska, Justyna Ukleja-Sokołowska, Natalia Bartuzi, Zbigniew |
author_sort | Kuźmiński, Andrzej |
collection | PubMed |
description | Treatment of eosinophilic gastroenteritis (EGE) is mainly empirical and is based on the assessment of symptom severity and the experience of clinicians. Patients with mild disease can be treated symptomatically, while patients with more severe symptoms or malabsorption symptoms require more aggressive therapy. So far, several therapeutic options have been proposed, including the following: dietary treatment, glucocorticosteroids, inhibitors of leukotriene receptors, mast cell stabilizers, immunomodulating drugs, and biological drugs. Unfortunately, there is still a lack of well-designed, prospective. and randomized clinical trials involving large groups of patients with EGE and assessing the effectiveness of individual treatments. More research is needed to compare the efficacy and safety profiles of the various treatments available, and to select the prognostic factors of relapse, which in turn will be extremely important in making decisions about the initial treatment phase and maintenance therapy. |
format | Online Article Text |
id | pubmed-10395056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-103950562023-08-03 Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment Kuźmiński, Andrzej Rosada, Tomasz Przybyszewska, Justyna Ukleja-Sokołowska, Natalia Bartuzi, Zbigniew Prz Gastroenterol Review Paper Treatment of eosinophilic gastroenteritis (EGE) is mainly empirical and is based on the assessment of symptom severity and the experience of clinicians. Patients with mild disease can be treated symptomatically, while patients with more severe symptoms or malabsorption symptoms require more aggressive therapy. So far, several therapeutic options have been proposed, including the following: dietary treatment, glucocorticosteroids, inhibitors of leukotriene receptors, mast cell stabilizers, immunomodulating drugs, and biological drugs. Unfortunately, there is still a lack of well-designed, prospective. and randomized clinical trials involving large groups of patients with EGE and assessing the effectiveness of individual treatments. More research is needed to compare the efficacy and safety profiles of the various treatments available, and to select the prognostic factors of relapse, which in turn will be extremely important in making decisions about the initial treatment phase and maintenance therapy. Termedia Publishing House 2022-08-09 2023 /pmc/articles/PMC10395056/ /pubmed/37538288 http://dx.doi.org/10.5114/pg.2022.118635 Text en Copyright © 2023 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Review Paper Kuźmiński, Andrzej Rosada, Tomasz Przybyszewska, Justyna Ukleja-Sokołowska, Natalia Bartuzi, Zbigniew Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment |
title | Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment |
title_full | Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment |
title_fullStr | Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment |
title_full_unstemmed | Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment |
title_short | Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment |
title_sort | eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? part 2. treatment |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395056/ https://www.ncbi.nlm.nih.gov/pubmed/37538288 http://dx.doi.org/10.5114/pg.2022.118635 |
work_keys_str_mv | AT kuzminskiandrzej eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment AT rosadatomasz eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment AT przybyszewskajustyna eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment AT uklejasokołowskanatalia eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment AT bartuzizbigniew eosinophilicgastroenteritisamanifestationofanallergicdiseaseinthegastrointestinaltractpart2treatment |